In vitro and in silico evaluation of new thieno [2, 3-d] pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2

SA El-Metwally, AA Abuelkhir, H Elkady… - … Biology and Chemistry, 2023 - Elsevier
In this study, new thieno [2, 3-d] pyrimidine derivatives that could have potential anticancer
activity by inhibiting the VEGFR-2 receptor have been designed, synthesized, and …
被引用次数：7 相关文章

In vitro and in silico evaluation of new thieno [2, 3-d] pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2.

SA El-Metwally, AA Abuelkhir, H Elkady… - Computational …, 2023 - europepmc.org
In this study, new thieno [2, 3-d] pyrimidine derivatives that could have potential anticancer
activity by inhibiting the VEGFR-2 receptor have been designed, synthesized, and …

In vitro and in silico evaluation of new thieno[2,3-d]pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2

SA El-Metwally, AA Abuelkhir, H Elkady, MS Taghour… - 2023 - dl.acm.org
In this study, new thieno [2, 3-d] pyrimidine derivatives that could have potential anticancer
activity by inhibiting the VEGFR-2 receptor have been designed, synthesized, and …

In vitro and in silico evaluation of new thieno [2, 3-d] pyrimidines as anti-cancer agents and apoptosis inducers targeting VEGFR-2

SA El-Metwally, AA Abuelkhir, H Elkady… - Computational … - pubmed.ncbi.nlm.nih.gov
In this study, new thieno [2, 3-d] pyrimidine derivatives that could have potential anticancer
activity by inhibiting the VEGFR-2 receptor have been designed, synthesized, and …